Badana Anil, Chintala Madhuri, Varikuti Gayathri, Pudi Nagaseshu, Kumari Seema, Kappala Vijaya Rachel, Malla Rama Rao
Cancer Biology Lab, Department of Biochemistry, GIS, GITAM University, Visakhapatnam, India.
Department of Obstetrics & Gynecology, Andhra Medical College, Visakhapatnam, India.
J Breast Cancer. 2016 Dec;19(4):372-384. doi: 10.4048/jbc.2016.19.4.372. Epub 2016 Dec 23.
Lipid rafts are cholesterol enriched microdomains that colocalize signaling pathways involved in cell proliferation, metastasis, and angiogenesis. We examined the effect of methyl-β-cyclodextrin (MβCD)-mediated cholesterol extraction on the proliferation, adhesion, invasion, and angiogenesis of triple negative breast cancer (TNBC) cells.
We measured cholesterol and estimated cell toxicity. Detergent resistant membrane (DRM) and non-DRM fractions were separated using the OptiPrep gradient method. Cell cycles stages were analyzed by flow cytometry, apoptosis was assessed using the TdT-mediated dUTP nick end-labeling assay, and metastasis was determined using a Matrigel invasion assay. Neo-vessel pattern and levels of angiogenic modulators were determined using an angiogenesis assay and an angiogenesis array, respectively.
The present study found that the cholesterol-depleting agent MβCD, efficiently depleted membrane cholesterol and caused concentration dependent (0.1-0.5 mM) cytotoxicity compared to nystatin and filipin III in TNBC cell lines, MDA-MB 231 and MDA-MB 468. A reduced proportion of caveolin-1 found in DRM fractions indicated a cholesterol extraction-induced disruption of lipid raft integrity. MβCD inhibited 52% of MDA-MB 231 cell adhesion on fibronectin and 56% of MDA-MB 468 cell adhesion on vitronectin, while invasiveness of these cells was decreased by 48% and 52% respectively, following MβCD treatment (48 hours). MβCD also caused cell cycle arrest at the GM phase and apoptosis in MDA-MB 231 cells (25% and 58% cells, respectively) and in MDA-MB 468 cells (30% and 38% cells, respectively). We found that MβCD treated cells caused a 52% and 58% depletion of neovessel formation in both MDA-MB 231 and MDA-MB 468 cell lines, respectively. This study also demonstrated that MβCD treatment caused a respective 2.6- and 2.5-fold depletion of tyrosine protein kinase receptor (TEK) receptor tyrosine kinase levels in both TNBC cell lines.
MβCD-induced cholesterol removal enhances alterations in lipid raft integrity, which reduces TNBC cell survival.
脂筏是富含胆固醇的微结构域,它使参与细胞增殖、转移和血管生成的信号通路共定位。我们研究了甲基-β-环糊精(MβCD)介导的胆固醇提取对三阴性乳腺癌(TNBC)细胞增殖、黏附、侵袭和血管生成的影响。
我们测量了胆固醇并评估了细胞毒性。使用OptiPrep梯度法分离抗去污剂膜(DRM)和非DRM组分。通过流式细胞术分析细胞周期阶段,使用TdT介导的dUTP缺口末端标记法评估细胞凋亡,并使用基质胶侵袭试验确定转移情况。分别使用血管生成试验和血管生成阵列确定新血管模式和血管生成调节剂水平。
本研究发现,与制霉菌素和菲律宾菌素III相比,胆固醇消耗剂MβCD在TNBC细胞系MDA-MB 231和MDA-MB 468中能有效消耗膜胆固醇,并引起浓度依赖性(0.1 - 0.5 mM)细胞毒性。在DRM组分中发现的小窝蛋白-1比例降低表明胆固醇提取诱导脂筏完整性破坏。MβCD抑制了52%的MDA-MB 231细胞在纤连蛋白上的黏附以及56%的MDA-MB 468细胞在玻连蛋白上的黏附,而在MβCD处理(48小时)后,这些细胞的侵袭性分别降低了